PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-24.16%
Revenue decline while VET shows 10.68% growth. Joel Greenblatt would examine competitive position erosion.
-48.99%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
79.55%
Gross profit growth exceeding 1.5x VET's 12.88%. David Dodd would verify competitive advantages.
136.75%
Margin expansion exceeding 1.5x VET's 1.98%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-16.67%
Other expenses reduction while VET shows 100.00% growth. Joel Greenblatt would examine efficiency.
-14.52%
Operating expenses reduction while VET shows 8.61% growth. Joel Greenblatt would examine advantage.
-42.16%
Total costs reduction while VET shows 5.64% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-16.67%
D&A reduction while VET shows 7.09% growth. Joel Greenblatt would examine efficiency.
86.21%
EBITDA growth exceeding 1.5x VET's 12.41%. David Dodd would verify competitive advantages.
145.54%
EBITDA margin growth exceeding 1.5x VET's 1.56%. David Dodd would verify competitive advantages.
2863.56%
Operating income growth exceeding 1.5x VET's 16.08%. David Dodd would verify competitive advantages.
3744.07%
Operating margin growth exceeding 1.5x VET's 4.87%. David Dodd would verify competitive advantages.
-122.54%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
53.01%
Pre-tax income growth exceeding 1.5x VET's 23.35%. David Dodd would verify competitive advantages.
101.76%
Pre-tax margin growth exceeding 1.5x VET's 11.45%. David Dodd would verify competitive advantages.
35.00%
Tax expense growth above 1.5x VET's 17.07%. Michael Burry would check for concerning trends.
66.67%
Net income growth exceeding 1.5x VET's 31.72%. David Dodd would verify competitive advantages.
119.78%
Net margin growth exceeding 1.5x VET's 19.01%. David Dodd would verify competitive advantages.
67.35%
EPS growth exceeding 1.5x VET's 35.71%. David Dodd would verify competitive advantages.
67.35%
Diluted EPS growth exceeding 1.5x VET's 28.57%. David Dodd would verify competitive advantages.
58.98%
Share count change of 58.98% while VET is stable. Bruce Berkowitz would verify approach.
58.98%
Diluted share change of 58.98% while VET is stable. Bruce Berkowitz would verify approach.